Lower bilirubin levels in newborns with hypoxic ischemic encephalopathy undergoing therapeutic hypothermia may indicate suppressed heme oxygenase activity
摘要
Despite having risk factors for hyperbilirubinemia, newborns with hypoxic ischemic encephalopathy (HIE) often exhibit unexpectedly low bilirubin levels, potentially due to reduced heme oxygenase (HO) activity. This study aims to evaluate bilirubin dynamics and HO activity in moderate to severe HIE newborns undergoing therapeutic hypothermia (TH) within a Japanese cohort. In this matched case–control study, newborns with HIE who underwent TH (case group) and control newborns without HIE (control group) treated at our perinatal center between 2019 and 2024 were retrospectively studied. Control newborns, admitted for respiratory distress or other conditions, were matched by gestational age, birth weight, sex, and birth date. Clinical data, including the total serum bilirubin (TsB), transcutaneous bilirubin (TcB), and carboxyhemoglobin (COHb) levels (an indicator of HO activity) were collected and analyzed during the first week of life. A total of 32 cases were analyzed in both the case and control groups. The case group had significantly lower TsB and TcB levels over time. COHb levels were comparable between the groups until 96 h of life but became significantly higher in the case group thereafter.
Conclusion: In this Japanese cohort, TsB and TcB levels were consistently lower in HIE newborns undergoing TH during the first week of life. COHb levels were initially comparable but increased later in the case group. These findings suggest that reduced HO activity may contribute to suppressed heme degradation in moderate to severe HIE cases receiving TH.